All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.
Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback